meningitis

New England News
12:00 am
Thu November 1, 2012

Drug Company to Recall All Products After Outbreak

A company with the same founders as the specialty pharmacy linked to deadly meningitis outbreak says it's recalling all its products.

In a statement Wednesday, Ameridose said the voluntary recall comes after FDA officials told the company it must improve its sterility testing. The Westborough company says it has no reports of problems with its products, or any impurities, but issued the recall "out of an abundance of caution."

The company did not say how many products it is recalling.

Read more
New England News
6:00 pm
Wed October 24, 2012

Massachusetts Officials Give Update on Meningitis Outbreak Investigation

Yesterday, Governor of Massachusetts Deval Patrick and the state Department of Public Health released more details of their investigation into the compounding pharmacy at the heart of a meningitis outbreak that has sickened more than 300 people.  WAMC’s Berkshire Bureau Chief Lucas Willard reports…

Since injectable steroids manufactured and distributed by New England Compound Center in Framingham Massachusetts were discovered to be the cause of an outbreak of fungal meningitis, the Commonwealth has launched an investigation with Federal officials on the incident.

Read more
New England News
9:00 pm
Tue October 23, 2012

Officials: Visible fungus at meningitis-linked company

Massachusetts state officials say they found unclean conditions including visible black specks of fungus in steroids made by a pharmacy linked to a deadly outbreak of meningitis.

Gov. Deval Patrick said Tuesday the state has moved to revoke the license of the New England Compounding Center and three pharmacists.

State officials say a preliminary investigation found drugs were sent out before tests results on their sterility could be returned and a leaking boiler was located near a company clean room.

Read more
New England News
8:00 pm
Fri October 19, 2012

Massachusetts Pharmacy Agrees to Remain Closed for Investigation

A pharmacy with the same owners as a Massachusetts specialty pharmacy at the center of a fungal meningitis outbreak that has killed 21 people has agreed to remain closed until at least Nov. 5.

Ameridose had agreed to a request from state regulators to temporarily shut down so it could be inspected. It was scheduled to reopen Monday.

The Board of Registration in Pharmacy said in a letter Friday to Ameridose's lawyer that it needs the extension to conduct "a comprehensive investigation of facility operations."

Read more
WAMC News
12:29 pm
Fri October 12, 2012

Health Officials Give Update on Meningitis Outbreak Investigation While Others Call for More Action

Center for Disease Control and Prevention

The outbreak of fungal meningitis linked to contaminated drugs manufactured by a Massachusetts company has claimed the lives of at least 14 people. Now federal and state officials are investigating but groups are calling for more action. WAMC’s Berkshire Bureau Chief Lucas Willard reports…

Read more
WAMC News
12:00 am
Fri October 12, 2012

Suit: Firm provided tainted meds in 2002, man died

Long before the current rash of fungal meningitis, the compounding pharmacy suspected in the outbreak settled a lawsuit alleging it produced a tainted shot that caused a man's death in 2004.

Officials have identified Framingham, Mass., based-New England Compounding Center as the source of steroid shots suspected in the outbreak of rare fungal meningitis that has killed at least 12 people and made more than 130 others sick in 10 states.

New England News
4:23 pm
Wed October 10, 2012

Mass. gov: Drug firm may have misled regulators

Massachusetts Gov. Deval Patrick says the specialty pharmacy linked to a deadly meningitis outbreak may have misled regulators and done work beyond the scope of its state license.

The New England Compounding Center in Framingham made a steroid that was used in contaminated injections that have sickened more than 130 people in 10 states. Twelve have died.

Patrick told reporters Wednesday that state and federal agencies "may have been misled by some of the information we were given."

Read more

Pages